Physician profile
John H Voltz
NPI 1942708664
$7,352.48
in general payments reported to CMS, 2019-2025
15 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.35 · 2021: $423 · 2022: $6,577 · 2023: $68.09 · 2024: $128 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,435.72 | 2022 | |
| Medical Device Business Services, INC. | $346.21 | 2021-2022 | |
| Abbvie INC. | $166.40 | 2020-2023 | Orilissa |
| Astellas Pharma US INC | $133.95 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $49.30 | 2022-2025 | Endosee |
| Pacira Pharmaceuticals Incorporated | $44.55 | 2024-2025 | Exparel |
| Hologic Sales and Service, LLC | $33.77 | 2022 | |
| Shield Therapeutics INC | $23.81 | 2025 | |
| Sumitomo Pharma America, INC. | $23.19 | 2025 | Myfembree |
| Coloplast Corp | $21.10 | 2023 | Altis |
| Baudax Bio INC. | $16.99 | 2022 | |
| Myovant Sciences INC. | $16.96 | 2022 | |
| Exeltis, USA INC. | $13.98 | 2023 | Slynd |
| Organon LLC | $13.47 | 2024 | |
| Meditrina | $13.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Voltz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.